These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bone marrow transplantation in chronic granulomatous disease. Kamani N; August CS; Douglas SD; Burkey E; Etzioni A; Lischner HW J Pediatr; 1984 Jul; 105(1):42-6. PubMed ID: 6376746 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literature. Leung T; Chik K; Li C; Shing M; Yuen P Bone Marrow Transplant; 1999 Sep; 24(5):567-70. PubMed ID: 10482944 [TBL] [Abstract][Full Text] [Related]
6. Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease. Ho CM; Vowels MR; Lockwood L; Ziegler JB Bone Marrow Transplant; 1996 Jul; 18(1):213-5. PubMed ID: 8832019 [TBL] [Abstract][Full Text] [Related]
7. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature. Del Giudice I; Iori AP; Mengarelli A; Testi AM; Romano A; Cerretti R; Macrì F; Iacobini M; Arcese W Ann Hematol; 2003 Mar; 82(3):189-92. PubMed ID: 12634956 [TBL] [Abstract][Full Text] [Related]
10. Selection of related and unrelated bone marrow donors. Goldmann SF Transplant Proc; 1977 Mar; 9(1):507-11. PubMed ID: 17197 [No Abstract] [Full Text] [Related]
11. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. Horwitz ME; Barrett AJ; Brown MR; Carter CS; Childs R; Gallin JI; Holland SM; Linton GF; Miller JA; Leitman SF; Read EJ; Malech HL N Engl J Med; 2001 Mar; 344(12):881-8. PubMed ID: 11259721 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group. Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428 [TBL] [Abstract][Full Text] [Related]
14. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K; Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834 [TBL] [Abstract][Full Text] [Related]
15. Successful bone marrow transplantation in an 8-month-old patient with chronic granulomatous disease. Kansoy S; Kütükçüler N; Aksoylar S; Aksu G; Kantar M; Cetingül N Turk J Pediatr; 2006; 48(3):253-5. PubMed ID: 17172071 [TBL] [Abstract][Full Text] [Related]
16. Donor selection for bone marrow transplantation: the predictive value of HLA-D typing for MLR compatibility between unrelated individuals. Dupont B; Hansen JA Transplant Proc; 1978 Mar; 10(1):53-6. PubMed ID: 147535 [No Abstract] [Full Text] [Related]
17. Successful hematopoietic stem cell transplantation in 2 children with X-linked chronic granulomatous disease from their unaffected HLA-identical siblings selected using preimplantation genetic diagnosis combined with HLA typing. Goussetis E; Konialis CP; Peristeri I; Kitra V; Dimopoulou M; Petropoulou T; Vessalas G; Papassavas A; Tzanoudaki M; Kokkali G; Petrakou E; Spiropoulos A; Pangalos CG; Pantos K; Graphakos S Biol Blood Marrow Transplant; 2010 Mar; 16(3):344-9. PubMed ID: 19835970 [TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367 [TBL] [Abstract][Full Text] [Related]